title: Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.
authors: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece ekastritis@gmail.com.
authors: Efstathios
authors: E
authors: Kastritis
authors: Hematology Section of the First Department of Propedeutic Internal Medicine, Laikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Greece.
authors: Marie-Christine
authors: MC
authors: Kyrtsonis
authors: Service D'Hématologie Clinique et Thérapie Cellulaire CHU (University Hospital), Amiens, France.
authors: Pierre
authors: P
authors: Morel
authors: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece.
authors: Maria
authors: M
authors: Gavriatopoulou
authors: Theagenion Cancer Center, Department of Hematology, Thessaloniki, Greece.
authors: Evdoxia
authors: E
authors: Hatjiharissi
authors: University of Patras, Hematology Division, Patras, Greece.
authors: Argirios S
authors: AS
authors: Symeonidis
authors: University of Ioannina, Hematology Division, Ioannina, Greece.
authors: Amalia
authors: A
authors: Vassou
authors: Peripheral General Anticancer Hospital-Metaxa, Department of Hematology, Piraeus, Greece.
authors: Panagiotis
authors: P
authors: Repousis
authors: Evangelismos Hospital, Hematology Department, Athens, Attica, Greece.
authors: Sossana
authors: S
authors: Delimpasi
authors: St Savvas Oncology Hospital, Hematology Division, Athens, Greece.
authors: Anastasia
authors: A
authors: Sioni
authors: G.Gennimatas General Hospital, Department of Hematology, Athens, Greece.
authors: Evrydiki
authors: E
authors: Michalis
authors: Department of Haematology, Nicosia General Hospital, Cyprus, Greece.
authors: Michail
authors: M
authors: Michael
authors: Henry Dunant Hospital, Hematology Division, Athens, Greece.
authors: Elina
authors: E
authors: Vervessou
authors: Department of Pathophysiology, National And Kapodistrian University of Athens, School of Medicine, Greece.
authors: Michael
authors: M
authors: Voulgarelis
authors: Democritus University of Thrace, Alexandroupolis, Greece.
authors: Costantinos
authors: C
authors: Tsatalas
authors: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece.
authors: Evangelos
authors: E
authors: Terpos
authors: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece.
authors: Meletios A
authors: MA
authors: Dimopoulos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D012307:Risk Factors; D000069283:Rituximab / Q000008:administration & dosage* / Q000009:adverse effects; D015996:Survival Rate; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D000069283:Rituximab
keywords: Rituximab; age; cyclophosphamide; fludarabine; lymphoma; prognosis